The Association of Depressive Symptoms with Inflammatory Factors and Adipokines in Middle-Aged and Older Chinese by Pan, An et al.
The Association of Depressive Symptoms with














1Key Laboratory of Systems Biology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and
Graduate School of the Chinese Academy of Sciences, Shanghai, China, 2Unilever Corporate Research, Colworth House, Sharnbrook, Bedfordshire,
United Kingdom, 3Beijing Center for Diseases Control and Prevention, Beijing, China, 4Shanghai Center for Diseases Control and Prevention,
Shanghai, China
Background. Studies in Western populations find that depression is associated with inflammation and obesity. The present
study aimed to evaluate the relation of depressive symptoms with inflammatory factors and adipose-derived adipokines in
middle-aged and older Chinese. Methodology/Principal Findings. Data were from 3289 community residents aged 50–70
from Beijing and Shanghai who participated in the Nutrition and Health of Aging Population in China project. Depressive
symptoms were defined as a Center for Epidemiological Studies of Depression Scale (CES-D) score of 16 or higher. Plasma
concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), adiponectin, resistin, plasminogen activator inhibitor-1 (PAI-1)
and retinol binding protein 4 (RBP4) were measured. Of the 3289 participants, 312 (9.5%) suffered from current depressive
symptoms. IL-6 level was higher in participants with depressive symptoms compared to their counterparts in the crude
analyses (1.17 vs. 1.05 pg/mL, p=0.023) and this association lost statistical significance after multiple adjustments (1.13 vs.
1.10 pg/mL, p=0.520). Depressive symptoms were not associated with increased mean levels of any other inflammatory
factors or adipokines in the unadjusted or adjusted analyses. Conclusions/Significance. We found no evidence that
depressive symptoms were associated with inflammatory factors and adipokines in the middle-aged and older Chinese
populations. Prospective studies and studies in clinically diagnosed patients are needed to confirm our results and clarify the
relation of depression with inflammatory factors and adipokines.
Citation: Pan A, Ye X, Franco OH, Li H, Yu Z, et al (2008) The Association of Depressive Symptoms with Inflammatory Factors and Adipokines in
Middle-Aged and Older Chinese. PLoS ONE 3(1): e1392. doi:10.1371/journal.pone.0001392
INTRODUCTION
Depression is a mental disorder significantly associated with
increased risk of the onset and mortality of cardiovascular diseases
(CVD) [1,2]. Several mechanisms have been proposed to explain
these observed associations, including poor compliance to
medications [3], elevated platelet reactivity [4], reduced heart
rate variability [5], increased cortisol and catecholamine levels
[6,7]. Of more recent interest is the role of inflammation and
obesity in the development of CVD [8,9] and their potential
relation to depression [10,11].
To date, numerous studies have suggested that chronic
inflammation is an intrinsic part of atherosclerosis [12] and plays
an important role in the pathogenesis of CVD [8]. It has become
established that C-reactive protein (CRP), a marker of systemic
inflammation, is an independent predictor of CVD [13,14].
Interleukin-6 (IL-6), an inflammatory cytokine and major inducer
of the secretion of CRP, is also associated with CVD [15]. Results
about the correlation between depression and inflammation are
inconsistent. Most studies found positive association [16–25], and
some reported null association [26,27], whereas one study even
found inverse association [28]. Nevertheless, all of the above
studies were conducted in Western countries and none has
investigated this association in Chinese populations.
Adipose tissue is now regarded as an endocrine organ and
secretes several adipokines, such as adiponectin, resistin, plasmin-
ogen activating inhibitor-1 (PAI-1) and retinol binding protein 4
(RBP4) [29–31]. In obesity, increased production of most
adipokines affects multiple functions such as appetite and energy
balance, lipid metabolism, insulin sensitivity, immunity, blood
pressure, angiogenesis, and hemostasis, all of which are linked with
CVD [32]. The association between obesity and depression has
been intensively studied in western populations and a recent
comprehensive review suggests that they are positively correlated,
particularly in women [33]. While a large cross-sectional study in
Chinese elderly in Hong Kong found negative association [34] and
few studies were done in mainland China. Meanwhile, the
association between depression and various adipose-derived
adipokines is sparsely studied and the few existing findings are
controversial [35–39].
Therefore, we sought to evaluate the association of clinical
relevant depressive symptoms with several inflammatory markers
and adipokines in a cross-sectional study of 3289 middle-aged and
older Chinese.
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Participants
The present study is part of the Nutrition and Health of Aging
Population in China project and the detailed study design has been
described previously [40,41]. In brief, a stratified, multi-stage
sampling method was adopted. One rural county and two urban
districts representing low, middle and upper socioeconomic levels
were chosen in both Beijing and Shanghai. In each selected county
or district, villages or communities were randomly selected and all
eligible potential participants were listed and asked the intention of
inclusion. The sampling procedure ended when we fulfilled our
designed sample size of 3200. Only one person per household was
randomly selected and a total of 3289 eligible participants (1458
men and 1831 women) were finally recruited. To be eligible,
participants should be non-institutionalized individuals of 50–
70 years old who were stable residents for at least 20 years in
Beijing or Shanghai. Participants were excluded from the study if
they had one of the following conditions: self-care disabilities;
severe psychological disorders; newly diagnosed with cancer,
coronary heart disease, stroke, Alzheimer’s disease and dementia
within the 6 month period before the start of the study; or
currently diagnosed with tuberculosis, AIDS and other commu-
nicable diseases. The study was approved by the Institutional
Review Board of the Institute for Nutritional Sciences, and signed
informed consent was obtained from each participant.
Depressive Symptoms
During the home interview, clinically relevant depressive symp-
toms were measured with the 20-item Center for Epidemiologic
Studies Depression Scale (CES-D) [42], which has been previously
validated in Chinese populations [43,44]. To identify respondents
with a level of depressive symptoms that is clinically relevant, we
used the generally accepted cutoff point of 16, which has a good
validity for major depression [45].
Inflammatory Markers
Peripheral venous Ethylene Diamine Tetraacetic Acid (EDTA) blood
samples were collected in the morning after at least 8 hours’ fasting.
The blood samples were centrifuged at 4uC, 3,000 rpm for
15 minutes. After being frozen, the samples were shipped in dry ice
to the Institute for Nutritional Sciences and stored at 280uCu n t i l
analysis. CRP was measured by a particle-enhanced immunoturbidi-
metric assay(OrionDiagnostica, Espoo, Finland)usingmicroparticles
coated with anti-human CRP antibodies.The lower detection limitof
the assay was 0.25 mg/L and the detailed assay procedure was
described previously [40]. IL-6 was measured with high-sensitivity
enzyme-linked immuno-sorbent assay (Quantikine HS IL-6 Immu-
noassay, R&D Systems Inc.,Minneapolis, MN). The linearrange was
0–10 pg/mL with low detect limit of 0.04 pg/mL. All undetectable
CRP values (,0.25 mg/L) were replaced with 0.12 mg/L and IL-6
level lower than 0.04 pg/mL was set to 0.02 pg/mL. A total of 96
individuals were excluded from IL-6 analysis due to gross hemolysis
o rl i p e m i aa c c o r d i n gt ot h ek i ti n s t r u c t i o n s .
Adipokines
Plasma adiponectin, resistin and active PAI-1 concentrations were
measured by Luminex xMAP
TM Technology (Linco Research Inc,
St Charles, Mo) on a Bio-Rad Multiplex Suspension Array
System. The sensitivity of the assay was 145.5, 6.7 and 1.3 pg/mL
for adiponectin, resistin and active PAI-1, respectively, with an
intra-assay coefficient of variation (CV) of 1.4–7.9% and an inter-
assay CV ,21%. Adipokines measurements were done simulta-
neously with IL-6 measurements, therefore the same 96 samples
were excluded from analyses.
Plasma RBP4 was measured in duplicate by an in-house
developed and validated sandwich ELISA, with an intra-assay CV
of 1.8–7.6% and an inter-assay CV of 3.7–8.8%. Detailed assay
procedure has been described elsewhere [46].
Other Biomarkers
Total cholesterol, triglycerides, and glucose were measured
enzymatically on an automatic analyzer (Hitachi 7080, Japan)
with reagents purchased from Wako Pure Chemical Industries
(Osaka, Japan). Fasting insulin was determined by radioimmuno-
assay (Linco Research, MO).
Covariates
Covariates included characteristics associated with depressive
symptoms, inflammation and adipokines as suggested by previous
publications. The study team was trained to conduct the face-to-
face home interviews using a standard questionnaire. Socio-
demographic variables included age, gender, geographic location
(Beijing/Shanghai), residential region (urban/rural) and educa-
tional level (#9o r.9 years in school). Current smoking status
(yes/no) and alcohol drinking status (yes/no) were also assessed.
The physical activity level for each individual was classified as low,
moderate, and high according to the International Physical
Activity Questionnaire (short last 7 day format) scoring protocol
[47] with minor modification. Body height and weight of the
participants were measured and body mass index (BMI) was then
calculated as weight (kg)/height
2 (m
2). Participants were catego-
rized as non-obese (,28.0 kg/m
2), obese ($28.0 kg/m
2) accord-
ing to the criteria for Chinese [48]. Blood pressure was measured
by using an electronic blood pressure monitor (Omron HEM-
705CP, OMRON Healthcare INC., Illinois). Information of anti-
inflammatory medications in the preceding two weeks and
presence of comorbidities (diabetes mellitus, cardiovascular
diseases, cerebrovascular diseases, cancer, asthma, chronic bron-
chitis, emphysema, pulmonary heart disease, gastrointestinal ulcer,
arthritis, rheumatic and rheumatoid arthritis) were obtained.
Diabetes mellitus was defined as fasting glucose $7.0 mmol/L, or
previously diagnosed type 2 diabetes or on treatment with oral
anti-diabetic agents or insulin. Other comorbidities were self-
reported. Binary categories of respondents were created according
to the presence or absence of any of the above comorbidities.
Statistical Analyses
Data were analyzed using Stata 9.2 (StataCorp, College Station,
Texas). A two-sided p value of 0.05 or less was defined as statistically
significant. Differences in proportions and means of covariates
between participants with and without depressive symptoms were
assessed using x
2 and t test statistics, respectively. General linear
regression analyses were used to compare mean levels of
inflammatory markers and adipokines between participants with
and without depressive symptoms, adjusted for potential confound-
ing variables (geographic location, residential region, age, gender,
educationallevel,smokingand drinking status,physicalactivitylevel,
BMI, log-triglyceride, log-insulin, log-total cholesterol, use of anti-
inflammatory medications and presence of comorbidity, listed in
table 1). For these analyses, natural log-transformations were
performed to approximate normality of CRP, IL-6, adiponectin,
resistin, PAI-1 and RBP4, as they were not normally distributed.
To further examine the associations, we used logistical regression
with elevated inflammatory factors or adipokines as a dichotomous
outcome variable and current depressive symptoms as a predictor
Depression and Inflammation
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as having values in the top quartile of each biomarker.
RESULTS
Of the 3289 participants, 312 (9.5%) suffered from current
depressive symptoms as indicated by a CES-D score $16. The
prevalence rates of depressive symptoms were higher in women and
participants from Beijing than their counterparts (Table 1). The
substantialdisparitybetween participantsfrom Beijing andShanghai
may be partly due to large variations in culture, lifestyle, dietary
habits, social support, living condition, and climate between the two
cities [41]. Presence of depressive symptoms was significantly
associated with low physical activity level and low educational level.
Higher prevalence of depressive symptoms was found in participants
using anti-inflammatory drugs and with comorbidities (particularly
inparticipantswithself-reportedCVD,datanotshown).Participants
with depressive symptoms had significantly higher fasting insulin
concentrations (14.51 vs. 13.33 mU/mL, p=0.008), higher systolic
blood pressure (142.8 vs. 139.8 mm Hg, p=0.028) compared to
those without depressive symptoms. People with depressive
symptoms had higher BMI (24.85 vs. 24.42 kg/m
2, p=0.064)and
higher prevalence of obesity (17.3% vs. 14.5%, p=0.191) than their
counterparts, while it did not reach statistical significance.
Current depressive symptoms were only associated with
increased IL-6 level in the crude analyses and this association
lost statistical significance after multiple adjustment (Table 2).
Depressive symptoms were not associated with increased mean
levels of any other inflammatory factors or adipokines in
unadjusted or adjusted analyses. When CES-D score was entered
as a continuous variable, we observed no evidence for a linear or
non-linear association of depressive symptoms with increased
levels of any of the factors evaluated (data not shown).
We confirmed in logistical regression analyses that depressive
symptoms were not associated with elevated levels of any of these
biomarkers (Table 3). No associations were either found in
subgroups stratified by geographic location, gender, obesity or
anti-inflammatory medications usage (data not shown).
DISCUSSION
In a sample of 3289 community residents from Beijing and
Shanghai, we found no evidence that depressive symptoms were
associated with increased levels of various inflammatory factors
(CRP and IL-6) and adipokines (adiponectin, resistin, PAI-1 and
RBP4). To the best of our knowledge, the present study is the first to
simultaneously investigate the association of depressive symptoms
with inflammatory factors and adipokines in Chinese populations.
Depressive Symptoms and Inflammatory Factors
The relation between depression and inflammation has been widely
studied with inconsistent results reported. Two studies found null
relation [26,27] and one study reported inverse association [28].
While some other large epidemiological studies found positive
relations in older American persons [16,17], young American adults
Table 1. Characteristics of Study Participants According to Depressive Symptoms
..................................................................................................................................................
n Depressive Symptoms (n=312) No Depressive Symptoms (n=2977) p Values
a
Age (years) 3289 58.2666.17 58.6465.99 0.285
Women 1831 214 (68.6%) 1617 (54.3%) ,0.001
Geographic Location ,0.001
Beijing 1641 224 (78.2%) 1397 (46.9%)
Shanghai 1648 68 (21.8%) 1580 (50.1%)
Residential Region 0.135
Rural 1649 143 (45.8%) 1697 (50.3%)
Urban 1640 169 (54.2%) 1480 (49.7%)
Current Smoker 920 77 (24.7%) 843 (28.3%) 0.173
Current Alcohol Drinker 939 82 (26.3%) 857 (28.8%) 0.351
Physical Activity Level ,0.001
Low 245 46 (14.7%) 199 (6.7%)
Moderate 1381 121 (38.8%) 1260 (42.3%)
High 1663 145 (46.5%) 1518 (51.0%)
Education Level (.9 years in school) 757 52 (16.7%) 705 (23.7%) 0.005
Anti-inflammatory Drugs 471 85 (27.2%) 386 (13.0%) ,0.001
Presence of Comorbidity 1295 152 (48.7%) 1143 (38.4%) ,0.001
Presence of Obesity
b 487 54 (17.3%) 433 (14.5%) 0.191
Body Mass Index (kg/m
2)
c 3289 24.8563.90 24.4263.55 0.064
Triglyceride (mmol/L)
c 3289 1.3960.97 1.3961.08 0.523
Total Cholesterol (mmol/L)
c 3289 4.8060.99 4.6960.98 0.054
Fasting Plasma Insulin (pmol/L)
c 3285 16.5369.28 15.3269.49 0.008
Systolic blood pressure (mmHg)
c 3289 142.8622.2 139.8622.5 0.028
Data are presented as n (%) or mean6SD.
ap values are based on x
2 tests for categorical variables and Student’s t-tests for continuous variables.
bObesity is defined as having a body mass index $28 kg/m
2.



















































































































PLoS ONE | www.plosone.org 3 January 2008 | Issue 1 | e1392[18,19] and adult Europeans [20,21], even after adjustment for
various confounding factors. Nevertheless, some other studies
suggested that this association might be mediated by various
confounders (such as poor health status, obesity and lifestyle). For
example, studies in adults aged $60 years living in Holland [22],
American persons free of CVD aged .65 years [23], young Finnish
adults [24] and community-dwelling men aged $70 years [25]. In
line of the above studies [22–25], we found in the present study that
depressive symptoms were associated with increased level of IL-6 in
the crude analyses, while this relation became non-significant after
adjustment for various confounding factors (including demographic
and lifestyle information, comorbidity, use of anti-inflammation
medications and other related biomarkers). Therefore, further
studies are still needed to evaluate whether inflammation and
depression are correlated in Chinese populations and the nature of
this association.
Depressive Symptoms and Adipokines
Previous studies have found that depression is positively associated
with obesity [33], while a large cross-sectional study in elderly
Chinese in Hong Kong found negative association [34]. Our study
is the first to investigate this association in mainland China and we
found that they were not correlated. One potential explanation for
our observed null association may be due to the inter-influence
and osmosis between Chinese traditional culture and the modern
opinion on obesity. Parallel to the ‘‘jolly fat’’ hypothesis [49] and a
well-known idiom of ‘‘happy mind and fat body’’ in Chinese
culture [34], being fat is a symbol of wealth and power rather than
unhappiness in traditional Chinese culture. However, in modern
China where there is increasing prevalence of obesity and
awareness of associated morbidity and mortality, stigma of obesity
and lower self-esteem of overweight people may be caused.
Therefore, it is really difficult to determine the relation between
depression and obesity, as we have no information of the
participants’ attitudes towards obesity.
The association between depression and adipose-derived adipo-
kines is a sparsely studied area and the direction remains unclear.
Leoetal.[35] found ina case-controlstudythatpatientswith clinical
diagnosed major depression displayed lower adiponectin levels
compared to the healthy controls and adiponectin significantly
correlated with depression severity. While Mamalakis et al. [36]
found null association between depression and adiponectin levels in
90 healthy adolescents. Another two case-control studies found that
depression was associated with higher levels of PAI-1 activity in men
[37] and premenopausal women [38]. Recently, a large longitudinal
study (Study of Women’s Health Across the Nation, SWAN) [39]
found that higher depressive symptoms were related to higher PAI-1
levels in perimenopausal women, while this association disappeared
after controlling for various confounding factors, particularly BMI.
Our study is the first to simultaneously evaluate the association
between depressive symptoms and various adipokines (adiponectin,
resistin, PAI-1and RBP4) ingeneralpopulations.One reason for the
lack of associations may be due to the fact that obesity was not
associated with depressive symptoms in our study populations.
Meanwhile, the endocrine function of adipose tissue is influenced by
both body composition (total fat mass and lean body mass) and fat
distribution (visceral and subcutaneous adiposity) [29], which are
more accurate parameters of describing obesity status than just BMI
alone, further studies are needed to evaluate whether body
composition and fat distribution are related to depression. Another
reasonisthatsomeoftheseadipokinesarenotexclusivelysecretedby
adipose tissues and could be secreted by other organs (for example,
resistin could be produced in peripheral blood monocytes [50], PAI-
1 and RBP4 could be synthesized in the liver, [29,51]).
Table 2. Plasma Levels of Inflammatory Factors and Adiopokines in Study Participants According to Depressive Symptoms
..................................................................................................................................................
Unadjusted Geometric Mean (95% CI) Adjusted Geometric Mean (95% CI)
a
Depressive Symptoms No Depressive Symptoms p Value
b Depressive Symptoms No Depressive Symptoms p Value
b
CRP (mg/L) 0.79 (0.69–0.91) 0.70 (0.67–0.73) 0.107 0.78 (0.68–0.90) 0.80 (0.74–0.86) 0.803
IL-6 (pg/mL) 1.17 (1.06–1.29) 1.05 (1.02–1.08) 0.023 1.13 (1.03–1.25) 1.10 (1.04–1.16) 0.520
Adiponectin (mg/mL) 13.06 (11.93–14.30) 12.77 (12.42–13.13) 0.622 11.80 (10.82–12.86) 12.07 (11.48–12.68) 0.585
Resistin (ng/mL) 9.64 (8..86–10.50) 8.97 (8.76–9.19) 0.110 9.59 (8.81–10.44) 9.23 (8.79–9.70) 0.362
PAI-1 (ng/mL) 9.06 (7.87–10.43) 8.80 (8.39–9.24) 0.713 9.07 (7.85–10.49) 10.32 (9.50–11.21) 0.068
RBP4 (mg/mL) 38.21 (36.86–39.61) 38.39 (37.98–38.81) 0.791 38.94 (37.60–40.33) 39.85 (39.06–40.65) 0.173
Data are presented as Geometric Mean (95% CI).
CRP, C-reactive protein; CI, confidence interval; IL-6, interleukin-6; PAI-1, plasminogen activator inhibitor-1; RBP4, retinol binding protein 4.
aAdjusted for geographic location, residential area, age, sex, body mass index, smoking status, drinking status, physical activity level, educational level, comorbidity
status, log-insulin, log-triglyceride, log-total cholesterol, log-systolic blood pressure, and use of anti-inflammatory drugs.


























































Table 3. Adjusted Odd Ratio of Elevated Inflammatory Factors




Risk of Elevated Biomarkers
b
(Depressive Symptoms: Yes vs. No) p Value
CRP ($1.51 mg/L) 0.99 (0.74–1.31) 0.920
IL-6 ($1.60 pg/mL) 1.01 (0.77–1.34) 0.931
Adiponectin ($21.72 mg/mL) 1.02 (0.76–1.37) 0.909
Resistin ($14.01 ng/mL) 1.14 (0.86–1.49) 0.363
PAI-1 ($19.45 ng/mL) 0.79 (0.58–1.08) 0.138
RBP4 ($46.85 mg/mL) 0.95 (0.71–1.27) 0.714
Data are presented as odd ratio (95% CI).
CRP, C-reactive protein; IL-6, interleukin-6; PAI-1, plasminogen activator
inhibitor-1; RBP4, retinol binding protein 4.
aAdjusted for geographic location, residential area, age, sex, body mass index,
smoking status, drinking status, physical activity level, educational level,
comorbidity status, log-insulin, log-triglyceride, log-total cholesterol, log-
systolic blood pressure, and use of anti-inflammatory drugs.
bElevated inflammatory factors or adipokines were defined as having values in
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The main strength of our study is that we used data from a large
population-based sample of both genders and from both northern
and southern China, which is representative of populations of this
age. Furthermore, we carefully controlled for various covariates
known to be related to inflammation, adipokines and depression in
the analyses.
Admittedly, certain limitations should be considered in
interpreting our results. Firstly, the validity of the findings based
on the self-reported measure of depression (CES-D) is inferior to
the psychiatric diagnostic interview, which is the gold standard.
However, the sensitivity of the CES-D to detect major depression
is high [41] and has been previously validated in Chinese
populations [39,40]. Secondly, this study was performed in a
population with narrow age range (50–70 years old) and may not
be generalizable to other age groups. Finally, we are unable to
determine the causal direction of any relation (or lack of relation)
due to the cross-sectional study design.
Conclusions
In conclusion, depressive symptoms are not associated with
inflammatory factors (CRP and IL-6) and adipokines (adiponectin,
resistin, PAI-1, RBP4) in the middle-aged and older Chinese
populations. Therefore, the relationship between depression and
CVD is unlikely to be explained through direct effects on
inflammatory factors and adipokines. Further studies, particularly
prospective studies and studies in clinically diagnosed patients, are
needed to confirm the results. Studies in different populations and
age groups are also warranted.
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